Request InformationCompany
For media inquiries, interview requests, or brand assets, please get in touch with our team.
Daniel Niendorff, Founder & CEO
Founded
2023
Headquarters
Knoxville, Tennessee
Regulatory Status
Pre-approval. FDA Safer Technologies Program (STeP) designation.
Clinical Trial
DECIBEL study: 2 ICUs, 311 patients. Results in peer review, pending publication.
View on ClinicalTrials.gov (NCT07364097)Patent
Granted: US 12,118,876 B1. Additional patents pending.
Recognized By
SCCM Innovation Incubator
February 2025 — Orlando, FL. Voted #1 Audience Choice Poster at the Society of Critical Care Medicine's first annual Critical Care Innovation Incubator.
WHX Miami Finalist
June 2026 — Miami, FL. Selected as a finalist among international medtech startups at the WHX Miami pitch competition.
Project Healthcare Accelerator
2026 Cohort — Nashville, TN. Currently participating in the Project Healthcare accelerator.
Learn more about Project HealthcareTeknovation.biz — May 27, 2025
How a critical care doctor is quietly reimagining hospital alarms
Read the article
Founder, CEO
Founder, COO
Founder, Chief Clinical Officer
Founder, Biomedical Engineering
Founder, KOL
Short
MindWave Medical is developing an alarm-routing system that delivers eligible hospital equipment alarms directly to the responsible staff, reducing unnecessary hospital noise and staff alarm fatigue.
Medium
MindWave Medical is developing a fail-safe alarm-routing system for hospitals. Built on the open IEEE 11073 SDC standard, MindWave routes eligible hospital equipment alarms directly to responsible staff members through a bone conduction headset in real time, cutting alarm fatigue and unnecessary noise while keeping life-threatening alarms audible. The company has completed an international clinical trial in India, and is part of the FDA's Safer Technologies Program.
Long
MindWave Medical was founded by a team of critical care physicians, who have a combined 100 years of bedside ICU experience. The company's alarm-routing platform, built on the open IEEE 11073 SDC standard, identifies which caregiver is responsible for which patient and piece of equipment in real time. Alarms are then delivered in plain-language alerts directly to a lightweight bone conduction headset instead of loudly broadcasting alarms to everyone — reducing alarm fatigue, nursing burnout, and the sleep disruption linked to hospital delirium.
MindWave has received FDA Safer Technologies Program (STeP) designation, completed a clinical trial in two ICUs in India, and is targeting U.S. market availability within approximately two years. MindWave Medical is headquartered in Knoxville, Tennessee. Its device is investigational and not yet available for sale in the United States.
Download the MindWave Medical logo files (PNG and SVG, light and dark versions) for use in press coverage and articles.